In pre-planned secondary analyses , a significant decrease in sweat chloride concentration occurred in the treatment groups between day @ and day @ ( lumacaftor @ mg once per day group -@ mmol/L , p < @ ; lumacaftor @ mg once per day group -@ mmol/L , p < @ ; lumacaftor @ mg every @ h group -@ mmol/L , p = @ ) .